Sirus Biocare Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 17-06-2024
- Paid Up Capital ₹ 2.00 M
as on 17-06-2024
- Company Age 19 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.25 Cr
as on 17-06-2024
- Satisfied Charges ₹ 1.28 Cr
as on 17-06-2024
- Revenue -16.10%
(FY 2023)
- Profit -84.94%
(FY 2023)
- Ebitda -284.49%
(FY 2023)
- Net Worth 2.94%
(FY 2023)
- Total Assets -11.68%
(FY 2023)
About Sirus Biocare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹1.25 Cr. The company has closed loans amounting to ₹1.28 Cr, as per Ministry of Corporate Affairs (MCA) records.
Prabir Saha, Pradipta Dasgupta, Sudipta Dasgupta, and One other member serve as directors at the Company.
- CIN/LLPIN
U24239WB2005PTC102576
- Company No.
102576
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Mar 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sirus Biocare?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sudipta Dasgupta  | Director | 31-Mar-2005 | Current |
| Prabir Saha | Director | 31-Mar-2005 | Current |
| Pradipta Dasgupta | Director | 31-Mar-2005 | Current |
| Tarit Ghosh | Director | 31-Mar-2005 | Current |
Financial Performance of Sirus Biocare.
Sirus Biocare Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 16.1% decrease. The company also saw a substantial fall in profitability, with a 84.94% decrease in profit. The company's net worth moved up by a moderate rise of 2.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sirus Biocare?
In 2023, Sirus Biocare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Diatek Healthcare Private LimitedActive 14 years 10 monthsPrabir Saha, Pradipta Dasgupta and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 01 Jul 2023 | ₹1.25 Cr | Open |
Hdfc Bank Limited Creation Date: 09 Jun 2014 | ₹6.00 M | Satisfied |
United Bank Of India Dharamtala Branch Creation Date: 07 Jan 2009 | ₹6.80 M | Satisfied |
How Many Employees Work at Sirus Biocare?
Sirus Biocare has a workforce of 20 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sirus Biocare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sirus Biocare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
